2. Signaling Pathways
  3. Neuronal Signaling
  4. Cholinesterase (ChE)
  5. Cholinesterase (ChE) Isoform
  6. Cholinesterase (ChE) Antagonist

Cholinesterase (ChE) Antagonist

Cholinesterase (ChE) Antagonists (4):

Cat. No. Product Name Effect Purity
  • HY-100907
    (±)-Acetylcarnitine chloride
    		Antagonist 99.60%
    (±)-Acetylcarnitine chloride (Acetyl dl-carnitine chloride) is a weak cholinergic agonist with cholinergic properties. (±)-Acetylcarnitine chloride is an important intermediate in lipid metabolism.
  • HY-B1277A
    Trihexyphenidyl
    		Antagonist
    Trihexyphenidyl is a potent and selective M1 muscarinic receptor antagonist. Trihexyphenidyl shows anticholinergic activity, and can be used for Parkinson syndrome or dystonia research.
  • HY-157959
    Orphenadrine
    		Antagonist
    Orphenadrine ((±)-Orphenadrine) is a skeletal muscle relaxant and NMDA antagonist that also has antiparkinsonian, antihistamine, antitremor, antispasmodic, and analgesic effects. Orphenadrine inhibits the binding of [3H]MK-801 to the phencyclidine (PCP) binding site of the NMDA receptor. Orphenadrine is also an anticholinergic and cytochrome P450 (CYP) 2B inducer. Orphenadrine may exert pro-tumor effects, causing CAR nuclear translocation, resulting in microsomal reactive oxygen species (ROS) production and oxidative stress. Orphenadrine also exerts neuronal protection, protecting rat cerebellar granule cells (CGC) from 3-NPA-induced death and has inhibitory potential against neurodegenerative diseases mediated by NMDA receptor overactivation.
  • HY-B0953A
    Pipenzolate bromide
    		Antagonist
    Pipenzolate bromide is a muscarinic receptor antagonist, preventing acetyl choline from binding to the receptors.